Skip to main content
OpenTrials

Clinical trial condition

Colonic Diseases

Explore clinical trials studying Colonic Diseases. Study availability and eligibility vary by location and protocol.

7,519 public trials 1,481 recruiting studies
Refine in advanced search Browse all conditions

Colonic Diseases trial results

Completed

A Study of Vismodegib (GDC-0449) in Patients Treated With Vismodegib in a Previous Genentech-sponsored Phase I or II Cancer Study

NCT00959647

Conditions
Adnexal Diseases, Basal Cell Carcinoma, Carcinoma, +29 more
Locations
  • TGen Clinical Research Srvs Scottsdale, Arizona, United States
  • Children's Hospital Oakland, California, United States
  • Comprehensive Cancer Care Palm Springs, California, United States
  • Stanford Univ Medical Center Stanford, California, United States
View Trial Details
Completed

Efficacy and Safety Study of ABX464 as Maintenance Therapy in Patients With Moderate to Severe Ulcerative Colitis

NCT04023396

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +6 more
Locations
  • Medizinische Universität Innsbruck Innsbruck, Austria
  • Klinikum Klagenfurt am Wörthersee Klagenfurt, Austria
  • Ordensklinikum Linz GmbH - Barmherzige Schwestern Linz, Austria
  • AKH - Medizinische Universität Wien Vienna, Austria
View all 120 locations
View Trial Details
Completed

A Study in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) Receiving Vedolizumab in Real-World Practice in Poland

NCT05384080

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +9 more
Locations
  • Uniwersytecki Szpital Kliniczny Wroclaw, Dolnoslskie, Poland
  • Samodzielny Publiczny Zaklad Opieki Zdrowotnej W Miedzychodzie Międzychód, Greater Poland Voivodeship, Poland
  • Szpital Kliniczny Im. Heliodora Swiecickiego Uniwersytetu Medycznego Im. Karola Marcinkowskiego W Poznaniu Poznan, Greater Poland Voivodeship, Poland
  • Szpital Uniwersytecki Nr 2 Im. Dr Jana Biziela W Bydgoszczy Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland
View Trial Details
Completed

Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005)

NCT03797326

Conditions
Adnexal Diseases, Advanced Solid Tumors, Astrocytoma, +49 more
Locations
  • City of Hope ( Site 0002) Duarte, California, United States
  • Cedars Sinai Medical Center ( Site 0003) Los Angeles, California, United States
  • University of California Davis Comprehensive Cancer Center ( Site 0005) Sacramento, California, United States
  • University of Colorado, Anschutz Cancer Pavilion ( Site 0007) Aurora, Colorado, United States
View all 88 locations
View Trial Details

Related conditions